David VanderWeele
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men With Localized, High Risk Prostate Cancer (NCT04737109) | David VanderWeele | 2021-07-13 |
Track David VanderWeele automatically
Every clearance here is in the API, with alerts when new ones post.